Original Research
Accepted on 03 Mar 2025
Design of a Peptide-Based Vaccine Against Human Respiratory Syncytial Virus (hRSV) Using a Reverse Vaccinology Approach: Evaluation of Immunogenicity, Antigenicity, Allergenicity, and Toxicity
in Vaccines and Molecular Therapeutics